Published recall report · Quality failureUpdated · 2 weeks ago
Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle
Recalled by Brandywine Pharmaceuticals, LLC
Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10.
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10.
- Producer
- Brandywine Pharmaceuticals, LLC
405620
- Dates on pack
- Lot: 405620, Expiry: 03/31/2028.
More detail
CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory
Loading related news…
See all US recall reports